Sanofi India · NSE: SANOFI · BSE: 500674
Q1 FY26 results · Apr–Jun 2025
Sanofi India reported revenue from operations of ₹406.30 crore (down 12.3% from Q1 FY25) and net profit of ₹69.50 crore (down 32.8% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a standalone basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 406.30 | 463.50 | −12.3% | 535.90 | −24.2% |
| Other income | 8.70 | 4.80 | +81.2% | 3.30 | +163.6% |
| Total income | 415.00 | 468.30 | −11.4% | 539.20 | −23.0% |
| Profit before tax | 94.10 | 92.10 | +2.2% | 165.30 | −43.1% |
| Net profit for the period | 69.50 | 103.40 | −32.8% | 119.50 | −41.8% |
| EPS, basic (₹) | 30.18 | 44.90 | −32.8% | 51.89 | −41.8% |
| Net margin (%) | 17.1 | 22.3 | 22.3 |
Standalone
- Filed with BSE
- 31 Jul 2025, 19:08 IST
- Board meeting
- 31 Jul 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE